Table 2. LOH of major tumor suppressor genes in each histology.
Gene | TP53 | NF1 | BRCA1 | RB1 | BRCA2 | |
---|---|---|---|---|---|---|
Chr | 17 | 17 | 17 | 13 | 13 | |
Cytoband | 17p13.1 | 17q11.2 | 17q21.2 | 13q14.2 | 13q13.2 | |
n = 13 | SC-1 | LOH | LOH | LOH | LOH | LOH |
SC-2 | LOH | LOH | LOH | LOH | LOH | |
SC-3 | LOH | LOH | LOH | LOH | LOH | |
SC-4 | LOH | LOH | LOH | LOH | LOH | |
SC-5 | LOH | LOH | LOH | LOH | LOH | |
SC-6 | LOH | LOH | LOH | LOH | LOH | |
SC-7 | CNN LOH | LOH | LOH | LOH | LOH | |
SC-8 | CNN LOH | CNN LOH | CNN LOH | LOH | LOH | |
SC-9 | LOH | LOH | LOH | nl | nl | |
SC-10 | LOH | CNN LOH | LOH | nl | nl | |
SC-11 | CNN LOH | LOH | LOH | nl | nl | |
SC-12 | CNN LOH | nl | nl | nl | nl | |
SC-13 | nl | nl | nl | nl | nl | |
n = 31 | CCC-1 | LOH | nl | nl | LOH | LOH |
CCC-2 | LOH | nl | nl | LOH | LOH | |
CCC-3 | LOH | nl | nl | LOH | nl | |
CCC-4 | LOH | nl | nl | nl | nl | |
CCC-5 | LOH | nl | nl | nl | nl | |
CCC-6 | LOH | nl | nl | nl | nl | |
CCC-7 | nl | nl | nl | LOH | LOH | |
CCC-8 | nl | nl | nl | CNN LOH | CNN LOH | |
Other 23 cases (CCC 9–31) | nl | nl | nl | nl | nl | |
n = 13 | EC-1 | LOH | LOH | LOH | CNN LOH | LOH |
EC-2 | LOH | nl | nl | nl | nl | |
EC-3 | LOH | nl | LOH | nl | nl | |
EC-4 | CNN LOH | LOH | CNN LOH | LOH | nl | |
EC-5 | CNN LOH | LOH | LOH | nl | nl | |
Other 8 cases (EC6-13) | nl | nl | nl | nl | nl |
nl: no copy number alterations, CNN LOH: Copy number neutral loss of heterozygosity.